Plasma Biomarkers of Reticular Pseudodrusen and the Risk of Progression to Advanced Age-Related Macular Degeneration

PURPOSE: To determine, using an aptamer-based technology in patients with intermediate age-related macular degeneration (AMD), (1) if there is a difference in plasma levels of 4979 proteins in patients with and without reticular pseudodrusen (RPD), and (2) if plasma levels of proteins are related to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynch, Anne M., Wagner, Brandie D., Palestine, Alan G., Janjic, Nebojsa, Patnaik, Jennifer L., Mathias, Marc T., Siringo, Frank S., Mandava, Naresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488626/
https://www.ncbi.nlm.nih.gov/pubmed/32974084
http://dx.doi.org/10.1167/tvst.9.10.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488626/
https://www.ncbi.nlm.nih.gov/pubmed/32974084
http://dx.doi.org/10.1167/tvst.9.10.12

Ejemplares similares